Article Information
History
- February 6, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Manuel M Vicente1,2,3,
- Inês Alves1,4,
- Ângela Fernandes1,
- Ana M Dias1,
- Elena Pérez-Anton1,
- Alexandra Correia1,2,
- Afonso R M Almeida5,
- Gabriel A Rabinovich6,7,8,
- Manuel Vilanova1,2,
- Ana E Sousa5 and
- Salomé S Pinho1,2,4,9,*
- 1i3S – Institute for Research and Innovation in Health, University of Porto, 4200-135 Porto, Portugal
- 2Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313 Porto, Portugal
- 3Graduate Program in Areas of Basic and Applied Biology (GABBA), ICBAS, University of Porto, 4050-313 Porto, Portugal
- 4Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal
- 5Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal
- 6Laboratorio de Inmunopatología, Instituto de Biología y Medicina Experimental (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), 1428 Ciudad de Buenos Aires, Argentina
- 7Laboratorio de Inmuno-oncología Translacional, Instituto de Biología y Medicina Experimental (IBYME), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), 1428 Ciudad de Buenos Aires, Argentina
- 8Facultad de Ciencias Exactas y Naturales (FCEyN), Universidad de Buenos Aires, 1428 Ciudad de Buenos Aires, Argentina
- ↵*Corresponding author: salomep{at}ipatimup.pt (S.S.P)
Posted February 06, 2022.
N-glycans mannosylation controls T-cell development by reprogramming thymocyte commitment, fate and repertoire
